The Only Complete Online Marketing Firm
Thursday, November 12, 2015
Anticoagulant Use Among Afib Patients Wanes Over Time (CME/CE)
(MedPage Today) -- Rivaroxaban has marginally better persistence rates versus other agents
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment